Sex-specific immune modulation of primary hypertension

Cellular Immunology

Volumn 294, Issue 2, 2015, Pages 95-101

  Sandberg, Kathryn ^a   Ji, Hong ^a   Hay, Meredith ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Hypertension; Inflammation; Kidney; Sex differences; Subfornical organ; T cells

Indexed keywords

CHEMOKINE; SEX HORMONE; HOMEODOMAIN PROTEIN; RAG-1 PROTEIN;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRAIN; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; ESSENTIAL HYPERTENSION; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOPEROXIDASE STAINING; INFLAMMATION; KIDNEY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SEX; SEX CHROMOSOME; SEX DIFFERENCE; VASCULARIZATION; ANIMAL; C57BL MOUSE; CD8+ T LYMPHOCYTE; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; MALE; MOUSE; PHYSIOLOGY; SEXUAL DEVELOPMENT; TRANSPLANTATION;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMALS; BLOOD PRESSURE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; HYPERTENSION; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SEX CHARACTERISTICS; SEX FACTORS;

EID: 84933047276     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.12.001     Document Type: Article

References (63)

1. J.A. Cutler, P.D. Sorlie, M. Wolz, T. Thom, L.E. Fields, E.J. Roccella, Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004, Hypertension 52 (2008) 818-827.
2. K. Sandberg, H. Ji, Sex differences in primary hypertension, Biol. Sex Differ. 3 (2012) 7.
3. T. Coutinho, Arterial stiffness and its clinical implications in women, Can. J. Cardiol. 30 (2014) 756-764.
4. M.A. Zimmerman, J.C. Sullivan, Hypertension: what's sex got to do with it?, Physiology 28 (2013) 234-244
5. R. Maranon, J.F. Reckelhoff, Sex and gender differences in control of blood pressure, Clin. Sci. 125 (2013) 311-318.
6. B. Xue, A.K. Johnson, M. Hay, Sex differences in angiotensin II- and aldosteroneinduced hypertension: the central protective effects of estrogen, Am. J. Physiol. Regul. Integr. Comp. Physiol. 305 (2013) R459-R463.
7. W. Kittikulsuth, J.C. Sullivan, D.M. Pollock, ET-1 actions in the kidney: evidence for sex differences, Br. J. Pharmacol. 168 (2013) 318-326.
8. M.M. Wenner, N.S. Stachenfeld, Blood pressure and water regulation: understanding sex hormone effects within and between men and women, J. Physiol. 590 (2012) 5949-5961.
9. J.F. Reckelhoff, C. Maric, Sex and gender differences in cardiovascular-renal physiology and pathophysiology, Steroids 75 (2010) 745-746.
10. V.M. Miller, D.M. Black, E.A. Brinton, M.J. Budoff, M.I. Cedars, H.N. Hodis, R.A. Lobo, J.E. Manson, G.R. Merriam, F. Naftolin, N. Santoro, H.S. Taylor, S.M. Harman, Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS), J. Cardiovasc. Transl. Res. 2 (2009) 228-239.
11. R. Lima, M. Wofford, J.F. Reckelhoff, Hypertension in postmenopausal women, Curr. Hypertens. Rep. 14 (2012) 254-260.
12. L. Pal, N. Santoro, Premature ovarian failure (POF): discordance between somatic and reproductive aging, Ageing Res. Rev. 1 (2002) 413-423.
13. J.A. Staessen, G. Ginocchio, L. Thijs, R. Fagard, Conventional and ambulatory blood pressure and menopause in a prospective population study, J. Hum. Hypertens. 11 (1997) 507-514.
14. B. Xue, J. Pamidimukkala, D.B. Lubahn, M. Hay, Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice, Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H1770-H1776.
15. B. Xue, D. Badaue-Passos Jr., F. Guo, C.E. Gomez-Sanchez, M. Hay, A.K. Johnson, Sex differences and central protective effect of 17beta-estradiol in the development of aldosterone/NaCl-induced hypertension, Am. J. Physiol. Heart Circ. Physiol. 296 (2009) H1577-H1585.
16. J.F. Reckelhoff, H. Zhang, J.P. Granger, Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats, Hypertension 31 (1998) 435-439.
17. D.L. Ely, M.E. Turner, Hypertension in the spontaneously hypertensive rat is linked to the Y chromosome, Hypertension 16 (1990) 277-281.
18. A.O. Davidson, N. Schork, B.C. Jaques, A.W. Kelman, R.G. Sutcliffe, J.L. Reid, A.F. Dominiczak, Blood pressure in genetically hypertensive rats. Influence of the Y chromosome, Hypertension 26 (1995) 452-459.
19. H. Ji, W. Zheng, X. Wu, J. Liu, C.M. Ecelbarger, R. Watkins, A.P. Arnold, K. Sandberg, Sex chromosome effects unmasked in angiotensin II-induced hypertension, Hypertension 55 (2010) 1275-1282.
20. D.G. Harrison, The immune system in hypertension, Trans. Am. Clin. Climatol. Assoc. 125 (2014) 130-138 (discussion 138-140).
21. D.G. Harrison, M.C. Gongora, T.J. Guzik, J. Widder, Oxidative stress and hypertension, J. Am. Soc. Hypertens. 1 (2007) 30-44.
22. H.E. Lob, P.J. Marvar, T.J. Guzik, S. Sharma, L.A. McCann, C. Weyand, F.J. Gordon, D.G. Harrison, Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system, Hypertension 55 (2010) 277-283 (276p following 283).
23. T.J. Guzik, N.E. Hoch, K.A. Brown, L.A. McCann, A. Rahman, S. Dikalov, J. Goronzy, C. Weyand, D.G. Harrison, Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction, J. Exp. Med. 204 (2007) 2449-2460.
24. J.F. Paton, H. Waki, Is neurogenic hypertension related to vascular inflammation of the brainstem?, Neurosci Biobehav. Rev. 33 (2009) 89-94.
25. J. Zubcevic, H. Waki, M.K. Raizada, J.F. Paton, Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension, Hypertension 57 (2011) 1026-1033.
26. A. Benigni, P. Cassis, G. Remuzzi, Angiotensin II revisited: new roles in inflammation, immunology and aging, EMBO Mol. Med. 2 (2010) 247-257.
27. D.G. Harrison, T.J. Guzik, H.E. Lob, M.S. Madhur, P.J. Marvar, S.R. Thabet, A. Vinh, C.M. Weyand, Inflammation, immunity, and hypertension, Hypertension 57 (2011) 132-140.
28. H. Ji, W. Zheng, X. Li, J. Liu, X. Wu, M.A. Zhang, J.G. Umans, M. Hay, R.C. Speth, S.E. Dunn, K. Sandberg, Sex-specific T-cell regulation of angiotensin IIdependent hypertension, Hypertension (2014).
29. T. Okuda, A. Grollman, Passive transfer of autoimmune induced hypertension in the rat by lymph node cells, Tex. Rep. Biol. Med. 25 (1967) 257-264.
30. F. Olsen, Transfer of arterial hypertension by splenic cells from DOCA-salt hypertensive and renal hypertensive rats to normotensive recipients, Acta Pathol. Microbiol. Scand. C 88 (1980) 1-5.
31. D. Ba, N. Takeichi, T. Kodama, H. Kobayashi, Restoration of T cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts, J. Immunol. 128 (1982) 1211-1216.
32. N. Rudemiller, H. Lund, H.J. Jacob, A.M. Geurts, D.L. Mattson, P.K. Program, CD247 modulates blood pressure by altering T-lymphocyte infiltration in the kidney, Hypertension 63 (2014) 559-564.
33. D.L. Mattson, H. Lund, C. Guo, N. Rudemiller, A.M. Geurts, H. Jacob, Genetic mutation of recombination activating gene 1 in Dahl salt-sensitive rats attenuates hypertension and renal damage, Am. J. Physiol. Regul. Integr. Comp. Physiol. 304 (2013) R407-R414.
34. D.P. Pollow, J. Uhrlaub, M.J. Romero-Aleshire, K. Sandberg, J. Nikolich-Zugich, H.L. Brooks, M. Hay, Sex differences in T-lymphocyte tissue infiltration and development of angiotensin II hypertension, Hypertension 64 (2014) 384-390.
35. D.A. Kasal, T. Barhoumi, M.W. Li, N. Yamamoto, E. Zdanovich, A. Rehman, M.F. Neves, P. Laurant, P. Paradis, E.L. Schiffrin, T regulatory lymphocytes prevent aldosterone-induced vascular injury, Hypertension 59 (2012) 324-330.
36. T. Barhoumi, D.A. Kasal, M.W. Li, L. Shbat, P. Laurant, M.F. Neves, P. Paradis, E.L. Schiffrin, T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury, Hypertension 57 (2011) 469-476.
37. A.J. Tipton, B. Baban, J.C. Sullivan, Female spontaneously hypertensive rats have greater renal anti-inflammatory T lymphocyte infiltration than males, Am. J. Physiol. Regul. Integr. Comp. Physiol. (2012).
38. J.A. Clayton, F.S. Collins, Policy: NIH to balance sex in cell and animal studies, Nature 509 (2014) 282-283.
39. A.J. Tipton, J.C. Sullivan, Sex differences in blood pressure control: are T lymphocytes the missing link?, Hypertension (2014)
40. E.L. Schiffrin, Immune mechanisms in hypertension: how do T-regulatory lymphocytes fit in?, J Hypertens. 31 (2013) 1944-1945.
41. E.L. Schiffrin, Immune mechanisms in hypertension and vascular injury, Clin. Sci. (Lond) 126 (2014) 267-274.
42. K.N. Brinson, A.A. Elmarakby, A.J. Tipton, G.R. Crislip, T. Yamamoto, B. Baban, J.C. Sullivan, Female SHR have greater blood pressure sensitivity and renal T cell infiltration following chronic NOS inhibition than males, Am. J. Physiol. Regul. Integr. Comp. Physiol. 305 (2013) R701-R710.
43. A.J. Tipton, B. Baban, J.C. Sullivan, Female spontaneously hypertensive rats have a compensatory increase in renal regulatory T cells in response to elevations in blood pressure, Hypertension 64 (2014) 557-564.
44. S. Johann, C. Beyer, Neuroprotection by gonadal steroid hormones in acute brain damage requires cooperation with astroglia and microglia, J. Steroid Biochem. Mol. Biol. 137 (2013) 71-81.
45. L.L. DonCarlos, I. Azcoitia, L.M. Garcia-Segura, Neuroprotective actions of selective estrogen receptor modulators, Psychoneuroendocrinology 34 (Suppl. 1) (2009) S113-S122.
46. P. Habib, C. Beyer, Regulation of brain microglia by female gonadal steroids, J. Steroid Biochem. Mol. Biol. (2014).
47. R.D. Spence, M.E. Hamby, E. Umeda, N. Itoh, S. Du, A.J. Wisdom, Y. Cao, G. Bondar, J. Lam, Y. Ao, F. Sandoval, S. Suriany, M.V. Sofroniew, R.R. Voskuhl, Neuroprotection mediated through estrogen receptor-alpha in astrocytes, Proc. Natl. Acad. Sci. U.S.A. 108 (2011) 8867-8872.
48. B. Xue, J. Pamidimukkala, M. Hay, Sex differences in the development of angiotensin II-induced hypertension in conscious mice, American journal of physiology, Heart Circ. Physiol. 288 (2005) H2177-H2184.
49. B. Xue, M. Singh, F. Guo, M. Hay, A.K. Johnson, Protective actions of estrogen on angiotensin II-induced hypertension: role of central nitric oxide, Am. J. Physiol. Heart Circ. Physiol. 297 (2009) H1638-H1646.
50. P.J. Marvar, H. Lob, A. Vinh, F. Zarreen, D.G. Harrison, The central nervous system and inflammation in hypertension, Curr. Opin. Pharmacol. 11 (2011) 156-161.
51. P.J. Marvar, S.R. Thabet, T.J. Guzik, H.E. Lob, L.A. McCann, C. Weyand, F.J. Gordon, D.G. Harrison, Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension, Circ. Res. 107 (2010) 263-270.
52. N. Laflamme, R.E. Nappi, G. Drolet, C. Labrie, S. Rivest, Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype, J. Neurobiol. 36 (1998) 357-378.
53. E.J. Spary, A. Maqbool, T.F. Batten, Oestrogen receptors in the central nervous system and evidence for their role in the control of cardiovascular function, J. Chem. Neuroanat. 38 (2009) 185-196.
54. B. Xue, Z. Zhang, T.G. Beltz, F. Guo, M. Hay, A.K. Johnson, Estrogen regulation of the brain renin-angiotensin system in protection against angiotensin IIinduced sensitization of hypertension, Am. J. Physiol. Heart Circ. Physiol. 307 (2014) H191-H198.
55. B. Xue, Y. Zhao, A.K. Johnson, M. Hay, Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species, Am. J. Physiol. Heart Circ. Physiol. 295 (2008) H1025-H1032.
56. M. Hay, B. Xue, A.K. Johnson, Yes! Sex matters: sex, the brain and blood pressure, Curr. Hypertens. Rep. 16 (2014) 458.
57. F. Samareh-Jahani, B. Xue, A.K. Johnson, M. Hay, Sex Differences in Microglia Activation During Subpressor Dose of Angiotensin (Ang) II Sensitization of Subsequent Pressor Dose of Ang II, Council on High Blood Pressure Research, 2014.
58. H.E. Lob, D. Schultz, P.J. Marvar, R.L. Davisson, D.G. Harrison, Role of the NADPH oxidases in the subfornical organ in angiotensin II-induced hypertension, Hypertension 61 (2013) 382-387.
59. A.V. Ferguson, Angiotensinergic regulation of autonomic and neuroendocrine outputs: critical roles for the subfornical organ and paraventricular nucleus, Neuroendocrinology 89 (2009) 370-376.
60. J. Ciriello, Afferent renal inputs onto subfornical organ neurons responsive to angiotensin II, Am. J. Physiol. 272 (1997) R1684-R1689.
61. M.P. Rosas-Arellano, L.P. Solano-Flores, J. Ciriello, Co-localization of estrogen and angiotensin receptors within subfornical organ neurons, Brain Res. 837 (1999) 254-262.
62. G. Wang, P. Sarkar, J.R. Peterson, J. Anrather, J.P. Pierce, J.M. Moore, J. Feng, P. Zhou, T.A. Milner, V.M. Pickel, C. Iadecola, R.L. Davisson, COX-1-derived PGE2 and PGE2 type 1 receptors are vital for angiotensin-II-induced formation of reactive oxygen species and Ca2+ influx in the subfornical organ, Am. J. Physiol. Heart Circ. Physiol. (2013).
63. X. Cao, J.R. Peterson, G. Wang, J. Anrather, C.N. Young, M.R. Guruju, M.A. Burmeister, C. Iadecola, R.L. Davisson, Angiotensin II-dependent hypertension requires cyclooxygenase 1-derived prostaglandin E2 and EP1 receptor signaling in the subfornical organ of the brain, Hypertension 59 (2012) 869-876.